Remepy
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
$36MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
Fabless semiconductor company building connectivity chips for hyperscale, edge, and AI data centers
Builds perception systems for Physical AI operating in complex environments
Pitching Key1 Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room